scholarly journals CardioPulse ArticlesHow heart failure took centre stage at record-breaking Heart Failure Association Congress in SevilleFrank Ruschitzka: elected new President of the European Society of Cardiology Heart Failure Association 2016–18The Fondation LeducqEuropean Society of Cardiology supports call for new European Union alcohol strategySTOP-HF Trial shows gene therapy stromal cell-derived factor-1 remodels hearts of high-risk heart failure patients: Figure 1

2015 ◽  
Vol 36 (36) ◽  
pp. 2408-2414
2019 ◽  
Vol 21 (Supplement_M) ◽  
pp. M68-M71 ◽  
Author(s):  
Michael Böhm ◽  
Andrew J S Coats ◽  
Ingrid Kindermann ◽  
Ilaria Spoletini ◽  
Giuseppe Rosano

Abstract Comorbidities are increasingly recognized as crucial components of the heart failure syndrome. Main specific challenges are polypharmacy, poor adherence to treatments, psychological aspects, and the need of monitoring after discharge. The chronic multimorbid patient therefore represents a specific heart failure phenotype that needs an appropriate and continuous management over time. This supplement issue covers the key points of a series of meeting coordinated by the Heart Failure Association of the European Society of Cardiology (ESC), that have discussed the issues surrounding the effective monitoring of our ever more complex and multimorbid heart failure patients. Here, we present an overview of the complex issues from a healthcare delivery perspective.


Sign in / Sign up

Export Citation Format

Share Document